JP2025169275A5 - - Google Patents

Info

Publication number
JP2025169275A5
JP2025169275A5 JP2025127770A JP2025127770A JP2025169275A5 JP 2025169275 A5 JP2025169275 A5 JP 2025169275A5 JP 2025127770 A JP2025127770 A JP 2025127770A JP 2025127770 A JP2025127770 A JP 2025127770A JP 2025169275 A5 JP2025169275 A5 JP 2025169275A5
Authority
JP
Japan
Prior art keywords
fcv
capsid protein
feline
acid sequence
immunogenic composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2025127770A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025169275A (ja
Filing date
Publication date
Priority claimed from PCT/EP2018/080096 external-priority patent/WO2019110213A1/en
Application filed filed Critical
Publication of JP2025169275A publication Critical patent/JP2025169275A/ja
Publication of JP2025169275A5 publication Critical patent/JP2025169275A5/ja
Pending legal-status Critical Current

Links

JP2025127770A 2017-12-08 2025-07-30 ネコカリシウイルスワクチン Pending JP2025169275A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201762596508P 2017-12-08 2017-12-08
US62/596,508 2017-12-08
PCT/EP2018/080096 WO2019110213A1 (en) 2017-12-08 2018-11-05 Feline calicivirus vaccine
JP2020524368A JP7374893B2 (ja) 2017-12-08 2018-11-05 ネコカリシウイルスワクチン
JP2023135198A JP7721604B2 (ja) 2017-12-08 2023-08-23 ネコカリシウイルスワクチン

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2023135198A Division JP7721604B2 (ja) 2017-12-08 2023-08-23 ネコカリシウイルスワクチン

Publications (2)

Publication Number Publication Date
JP2025169275A JP2025169275A (ja) 2025-11-12
JP2025169275A5 true JP2025169275A5 (https=) 2025-12-02

Family

ID=64316487

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2020524368A Active JP7374893B2 (ja) 2017-12-08 2018-11-05 ネコカリシウイルスワクチン
JP2023135198A Active JP7721604B2 (ja) 2017-12-08 2023-08-23 ネコカリシウイルスワクチン
JP2025127770A Pending JP2025169275A (ja) 2017-12-08 2025-07-30 ネコカリシウイルスワクチン

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP2020524368A Active JP7374893B2 (ja) 2017-12-08 2018-11-05 ネコカリシウイルスワクチン
JP2023135198A Active JP7721604B2 (ja) 2017-12-08 2023-08-23 ネコカリシウイルスワクチン

Country Status (3)

Country Link
JP (3) JP7374893B2 (https=)
AU (2) AU2018380582B2 (https=)
WO (1) WO2019110213A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108473539B (zh) * 2015-12-23 2022-03-22 英特维特国际股份有限公司 猫杯状病毒疫苗
WO2019115090A1 (en) * 2017-12-15 2019-06-20 Intervet International B.V. Multivalent feline vaccine
US11229699B2 (en) 2017-11-06 2022-01-25 Intervet Inc. Feline calicivirus vaccine
WO2021228731A1 (en) * 2020-05-11 2021-11-18 Intervet International B.V. Feline severe acute respiratory syndrome coronavirus 2 vaccine

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003527584A (ja) * 2000-03-09 2003-09-16 ヘスカ コーポレイション 動物の免疫状態を決定するための組換え抗原の使用
US7309495B2 (en) 2003-03-14 2007-12-18 The Regents Of The University Of California Hemorrhagic feline calicivirus
EP1751289B1 (en) * 2004-05-18 2009-01-14 Alphavax, Inc. Tc-83-derived alphavirus vectors, particles and methods
DK2947149T3 (en) 2007-06-21 2018-06-06 Alphavax Inc ALPHAVIRUS REPLICATION PARTICLES FOR USE IN VACCINATION
CN108473539B (zh) * 2015-12-23 2022-03-22 英特维特国际股份有限公司 猫杯状病毒疫苗

Similar Documents

Publication Publication Date Title
JP2025169275A5 (https=)
Pushko et al. Replicon-helper systems from attenuated venezuelan equine encephalitis virus: Expression of heterologous genesin vitroand immunization against heterologous pathogensin vivo
Baron et al. Rescue of rinderpest virus from cloned cDNA
US10894079B2 (en) Chromatography based purification strategies for viruses
Liu et al. Rift Valley fever virus structural proteins: expression, characterization and assembly of recombinant proteins
JP2025169249A5 (https=)
JPH08168381A (ja) 組換え伝染性非セグメント化陰性鎖rnaウイルス
JP7721604B2 (ja) ネコカリシウイルスワクチン
JP7731670B2 (ja) ネコ白血病ウイルスワクチン
García-Sastre et al. Novel vaccine strategies against emerging viruses
AU2025279721A1 (en) Multivalent feline vaccine
JP2025170230A5 (https=)
EP1736539A1 (en) Attenuated SARS-CoV vaccines
CN111315409A (zh) 狂犬病毒疫苗
WO2006009011A1 (ja) コロナウイルススパイクs1融合蛋白及びその発現ベクター
Allam et al. Perspective vaccines for emerging viral diseases in farm animals
CN113430178B (zh) 一种表达ii型单纯疱疹病毒蛋白的重组流感病毒株及其制备方法与应用
WO2006038742A1 (ja) 組み換えウイルスおよびその用途
CN115768472A (zh) 包含具有特定基因顺序的核酸构建体的甲型猪流感病毒疫苗
CN115697398A (zh) 包含两种不同rna复制子颗粒的甲型猪流感病毒疫苗
CN115887634B (zh) 鸡传染性支气管炎二价亚单位疫苗及应用
Koukuntla et al. Virus‐like particle‐based countermeasures against Rift Valley fever virus
US12502425B2 (en) Multivalent virus like particle vaccines
CN115820738A (zh) 一种腺病毒重组狂犬病疫苗及其制备方法和应用
CN102643335A (zh) 重组轮状病毒vp6载体蛋白及其制备